604 Page 1 of 2 15 July 2001 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme GENETIC SIGNATURES LIMITED ACN/ARSN 095 913 205 1. Details of substantial holder (1) ...
Change in Substantial Shareholder Notice for GSS
Filed with ASX ·
6ix hasn’t read this filing yet.
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Notification regarding unquoted securities - BDX
- BCAL Secures Funding for FY2027 Update
- Proposed issue of securities - BDX
- Bioshares Conference Investor Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from BCAL Diagnostics
- BCAL Takes Interest in Genetic Signatures to 18.46%
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Annual Report to shareholders
- Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM
- Investor Presentation September 2026
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics